Our authored documents, platform science, neo-organ application, and other clinical information are detailed in our publications section below. If you have any questions about our papers, please contact us.
Clinical
Renal autologous cell therapy (REACT) to stabilize function in diabetes-related chronic kidney disease: corroboration of mechanism of action with cell marker analysis
Kidney Intl Reports. April 11, 2022. DOI: https://doi.org/10.1016/j.ekir.2022.04.014
Joseph Stavas, MD, MPH, Guido Filler, MD, PhD, Deepak Jain, PhD,
John Ludlow, PhD, Joydeep Basu, PhD, Richard Payne, PhD, Emily Butler, PhD
Maria Díaz-González de Ferris, MD, PhD, MPH, and Tim Bertram, PhD
Clinical
Novel Renal Autologous Cell Therapy (REACT) for Type 2 Diabetes Mellitus Chronic Diabetic Kidney Disease: Clinical Trial Design
American Journal of Nephrology. Jan 14, 2022, https://doi.org/10.1159/000520231
Joseph Stavas, David Gerber, Steven G. Coca, Arnold L. Silva, Ashley Johns, Deepak Jain, Tim Bertram, Maria Díaz-González de Ferrise, George Bakris
Clinical
Protocol and baseline data on renal autologous cell therapy injection in adults with Chronic Kidney Disease secondary to Congenital Anomalies of the Kidney and Urinary Tract
Blood Purification, March 1, 2021 DOI: 10.1159/000512586
Joseph Stavas, Maria Diaz-Gonzalez de Ferris, Ashley Johns, Deepak Jain, Tim Bertram
Clinical
SAFETY AND FEASIBILITY OF A NOVEL PERCUTANEOUS LOCOREGIONAL INJECTION TECHNIQUE OF RENAL CELLULAR THERAPY FOR CHRONIC KIDNEY DISEASE OF DIABETES
Hyeon Yu , Paul D. Sonntag , Peter R. Bream , Michael P. Lazarowicz, Francis S. Nowakowski, Gregory J. Woodhead, Charles T. Hennemeyer, Ryan D. Muller, Rakesh Navuluri, Elaine M. Caoili, Aaron C. Eifler, Brandon S. Tominna and Joseph M. Stavas
Clinical
RENAL AUTOLOGOUS CELL Therapy/NEO-KIDNEY AUGMENT TM (REACT/NKA): PHASE II STUDY OF REACT/NKA IMPLANTATION IN Type 2 DIABETES WITH CHRONIC KIDNEY DISEASE
Joseph Stavas, Tim Bertram, Ashley Johns, Deepak Jain, David Gerber, Prabir Roy-Chaudhury, George Bakris
Clinical
RENAL AUTOLOGOUS CELL THERAPY/NEO-KIDNEY AUGMENT TM (REACT/NKA): PHASE II STUDY OF REACT/NKA IMPANTATION IN TYPE 2 DIABETES WITH PRE-STAGE 5 CHRORIC KIDNEY DISEASE
Joseph Stavas, Tim Bertram, Deepak Jain, Ashely Johns, David Gerber, Prabir Roy-Chaudhury , George Bakris
Clinical
IMPLANTATION OF AUTOLOGOUS SELECTED RENAL CELLS IN DIABETIC CHRONIC KIDNEY DISEASE STAGES 3 AND 4—CLINICAL EXPERIENCE OF A “FIRST IN HUMAN” STUDY
Peter Stenvinkel, Jonas Wadström, Tim Bertram, Randal Detwiler, David Gerber,
Torkel B. Brismar, Pontus Blomberg and Torbjörn Lundgren
Pre-Clinical
A POPULATION OF SELECTED RENAL CELLS AUGMENTS RENAL FUNCTION AND EXTENDS SURVIVAL IN THE ZSF1 MODEL OF PROGRESSIVE DIABETIC NEPHROPATHY
Rusty Kelley, Andrew Bruce, Tom Spencer, Eric Werdin, Roger Ilagan, Sumana Choudhury, Elias Rivera, Shay Wallace, Kelly Guthrie, Manuel Jayo, Fengfeng Xu, Anjali N. Rao, Benjamin D. Humphreys, Sharon Presnell and Tim Bertram
Pre-Clinical
A TUBULAR CELL-ENRICHED SUBPOPULATION OF PRIMARY RENAL CELLS IMPROVES SURVIVAL AND AUGMENTS KIDNEY FUNCTION IN A RODENT MODEL OF CHRONIC KIDNEY DISEASE.
Kelley R., Werdin E.S., Bruce A.T., Choudhury S., Wallace S.M., Ilagan R.M., Cox B.R., Tatsumi-Ficht P., Rivera E.A., Spencer T., Rapoport H.S., Wagner B.J., Guthrie K., Jayo M.J., Bertram T.A., Presnell S.C. (2010, September 8).
Tubular cell-enriched subpopulation of primary renal cells improves survival and augments kidney function in rodent model of chronic kidney disease
Am J Physiol Renal Physiol (September 8, 2010). doi:10.1152/ajprenal.00221.2010
Pre-Clinical
MOLECULAR CHARACTERIZATION OF THE REGENERATIVE RESPONSE INDUCED BY INTRARENAL TRANSPLANTATION OF SELECTED RENAL CELLS IN A RODENT MODEL OF CHRONIC KIDNEY DISEASE
Genheimer, W.G., Ilagan R.M., Spencer T., Kelley R., Werdin E., Choudhury S., Jain D., Ludlow J.W., Basu J. (2012). Molecular Characterization of the Regenerative Response Induced by Intrarenal Transplantation of Selected Renal Cells in a Rodent Model of Chronic Kidney Disease. Cells Tissues Organs 2012;196:374–384
Pre-Clinical
FUNCTIONAL EVALUATION OF PRIMARY RENAL CELL/BIOMATERIAL NEO-KIDNEY AUGMENT PROTOTYPES FOR RENAL TISSUE ENGINEERING
Basu J., Genheimer C.W., Rivera E.A., Payne R., Mihalko K., Guthrie K., Bruce A.T., Robbins N., McCoy D., Sangha N., Ilagan R., Knight T., Spencer T., Wagner B.J., Jayo M.J., Jain D., Ludlow J.W., Halberstadt C. (2011, March). Functional evaluation of primary renal cell/biomaterial Neo-Kidney Augment prototypes for renal tissue engineering Cell Transplant. 2011 Mar 24. doi: 10.3727/096368911X566172.
Pre-Clinical
ISOLATION, CHARACTERIZATION, AND EXPANSION (ICE) METHODS FOR DEFINED PRIMARY RENAL CELL POPULATIONS FROM RODENT, CANINE, AND HUMAN NORMAL AND DISEASED KIDNEYS.
Presnell S.C., Bruce A.T., Wallace S.M., Choudhury S., Genheimer C., Cox B., Guthrie K.I., Werdin E.S., Tatsumi-Ficht P., Ilagan R., Kelley R.W., Rivera E.A., Ludlow J.W., Wagner B.J., Jayo M.J., Bertram T. (2010, September 16) Isolation, Characterization, and Expansion (ICE) Methods for Defined Primary Renal Cell Populations from Rodent, Canine, and Human Normal and Diseased Kidneys.Tissue Eng Part C Methods. 2010 Sep 16.